Atara Biotherapeutics, Inc. (LON:0HIY)
6.52
-0.76 (-10.44%)
At close: May 13, 2025
Atara Biotherapeutics Revenue
In the year 2024, Atara Biotherapeutics had annual revenue of $128.94M USD with 1,404.02% growth. Atara Biotherapeutics had revenue of $32.75M in the quarter ending December 31, 2024, with 670.30% growth.
Revenue
$128.94M
Revenue Growth
+1,404.02%
P/S Ratio
0.20
Revenue / Employee
$842.75K
Employees
153
Market Cap
30.22M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Atara Biotherapeutics News
- 11 days ago - Atara Biotherapeutics Provides Regulatory Updates on EBVALLO™ (tabelecleucel) - Business Wire
- 2 months ago - Atara Biotherapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Operational Progress - Business Wire
- 2 months ago - An Investigation Has Been Launched Into Atara Biotherapeutics, Inc. For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm - Accesswire
- 2 months ago - The Schall Law Firm Invites Investors With Losses In Atara Biotherapeutics, Inc. To Join A Securities Fraud Investigation - Accesswire
- 2 months ago - The Schall Law Firm Invites Investors With Losses In Atara Biotherapeutics, Inc. To Join A Securities Fraud Investigation - Accesswire
- 2 months ago - An Investigation Has Been Launched Into Atara Biotherapeutics, Inc. For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm - Accesswire
- 3 months ago - Atara Biotherapeutics, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm - Accesswire
- 3 months ago - The Schall Law Firm Invites Shareholders With Losses In Atara Biotherapeutics, Inc. To Join A Securities Fraud Investigation - Accesswire